Table 5.

Cancer risk calculated from the mean chronic dietary exposure to ‘aflatoxin total’^a, the mean potency estimates of the cancer risk and a prevalence of HBsAg of 0.01%

Age classb	Scenario	N	Cancer risk (aflatoxin‐induced cancers per year and per 100,000 subjects)
			Minimum		Median		Maximum
			LB	UB	LB	UB	LB	UB
Infants	Current ML	2	0.001	0.001	0.003	0.004	0.005	0.006
	Increased ML	2	0.001	0.001	0.005	0.005	0.008	0.010
Toddlers	Current ML	5	0.007	0.009	0.012	0.016	0.022	0.028
	Increased ML	5	0.012	0.014	0.021	0.025	0.038	0.044
Other children	Current ML	16	0.005	0.007	0.014	0.018	0.029	0.039
	Increased ML	16	0.009	0.011	0.024	0.028	0.050	0.060
Adolescents	Current ML	14	0.002	0.003	0.009	0.012	0.035	0.047
	Increased ML	14	0.004	0.005	0.015	0.018	0.061	0.073
Adults	Current ML	17	0.003	0.004	0.009	0.011	0.021	0.029
	Increased ML	17	0.005	0.006	0.015	0.018	0.037	0.045
Elderly	Current ML	12	0.001	0.002	0.006	0.008	0.013	0.017
	Increased ML	12	0.002	0.003	0.010	0.012	0.022	0.026
Very elderly	Current ML	4	0.004	0.005	0.006	0.008	0.012	0.017
	Increased ML	4	0.006	0.008	0.011	0.012	0.022	0.026

LB: lower bound; ML: maximum level; N: number of surveys; UB: upper bound.

^aMean chronic dietary exposure to ‘aflatoxin total’ from peanuts, peanut butter and processed products thereof (consumers only) calculated from mean LB and UB occurrence values for two different scenarios.

^bSection 2.4 describes the age range within each age class.